138 related articles for article (PubMed ID: 37278933)
1. The high expression of FOXE1 in colorectal cancer predicts a promising prognosis: a retrospective study.
Liu X; Chen L; Wen F; Zheng S; Ge W
Clin Exp Med; 2023 Nov; 23(7):3995-4001. PubMed ID: 37278933
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
[TBL] [Abstract][Full Text] [Related]
3. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer.
Dai W; Meng X; Mo S; Xiang W; Xu Y; Zhang L; Wang R; Li Q; Cai G
Cell Commun Signal; 2020 Jan; 18(1):7. PubMed ID: 31918722
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1.
Zhang Y; Ma LN; Xie Y
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1778-1785. PubMed ID: 32141546
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
6. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
7. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
8. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
10. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study.
Wang Y; Yang W; Liu T; Bai G; Liu M; Wang W
Medicine (Baltimore); 2019 Jul; 98(27):e16237. PubMed ID: 31277140
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box E1, frequently downregulted by promoter methylation, inhibits colorectal cancer cell growth and migration.
Shi Q; Huang Z; Kuang Y; Wang C; Fang X; Hu X
Cancer Cell Int; 2024 May; 24(1):169. PubMed ID: 38734646
[TBL] [Abstract][Full Text] [Related]
13. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
14. High expression of SHP2 predicts a promising prognosis in colorectal cancer.
Liu X; Li M; Chen L; Wen F; Zheng S; Ge W
Indian J Pathol Microbiol; 2024; 67(1):29-35. PubMed ID: 38358185
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
[TBL] [Abstract][Full Text] [Related]
16. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
18. AC133 expression associated with poor prognosis in stage II colorectal cancer.
Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.
Zhou K; Liang H; Liu Y; Yang C; Liu P; Jiang X
Tumour Biol; 2013 Dec; 34(6):3691-9. PubMed ID: 23852859
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
